Home - Products - Membrane Transporter/Ion Channel - TRP/TRPV Channel - N4-benzyl-N2-methylquinazoline-2,4-diamine hydrochloride

N4-benzyl-N2-methylquinazoline-2,4-diamine hydrochloride

CAS No. 1135272-09-1

N4-benzyl-N2-methylquinazoline-2,4-diamine hydrochloride( —— )

Catalog No. M22212 CAS No. 1135272-09-1

N4-benzyl-N2-methylquinazoline-2,4-diamine hydrochloride is an inhibitor of TRPC4.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 169 In Stock
5MG 169 In Stock
10MG 258 In Stock
25MG 426 In Stock
50MG 586 In Stock
100MG 792 In Stock
200MG 1051 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    N4-benzyl-N2-methylquinazoline-2,4-diamine hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    N4-benzyl-N2-methylquinazoline-2,4-diamine hydrochloride is an inhibitor of TRPC4.
  • Description
    N4-benzyl-N2-methylquinazoline-2,4-diamine hydrochloride is an inhibitor of TRPC4.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    TRP/TRPV Channel
  • Recptor
    TRPC4
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1135272-09-1
  • Formula Weight
    300.79
  • Molecular Formula
    C16H17ClN4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CNc3nc(NCc1ccccc1)c2ccccc2n3.[Cl]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • (S)-ABT 102

    N-[(1S)-5-tert-butyl-2,3-dihydro-1H-inden-1-yl]-N'-1H-indazol-4-ylurea is a potent TRPV1 antagonist, blocking activation of TRPV1 by capsaicin with the IC50 of 123 nM.

  • MDR-652

    MDR-652 is a highly specific and efficacious agonist of nonpungent transient receptor potential vanilloid 1 (TRPV1) with Ki value of 11.4 nM and 23.8 nM for hTRPV1 and rTRPV1 respectively and EC50s for hTRPV1 and rTRPV1 are 5.05 and 93 nM respectively.

  • Elismetrep

    Elismetrep (MT-8554) is an orally available TRPM8 inhibitor with potential analgesic activity for the study of vasomotor symptoms in postmenopausal women.